|
Volumn 34, Issue 3, 2002, Pages 172-177
|
Enhanced regression of tumors in mice with combined chemotherapy and immunotherapy
a
a
a
a
|
Author keywords
Antimetabolite; Chemoimmunotherapy; Cytotoxic agents; Ehrlich ascites carcinoma; Immunopotentiators
|
Indexed keywords
5 N METHYL 2 (4' ETHYL BENZENESULFONYL)GLUTAMINE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
CYTOTOXIC AGENT;
GLUTAMINE ANTAGONIST;
METHOTREXATE;
TUMOR CELL VACCINE;
TUMOR EXTRACT;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BODY WEIGHT;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
EHRLICH ASCITES TUMOR;
HUMORAL IMMUNITY;
IMMUNE RESPONSE;
IMMUNOPOTENTIATION;
LONG TERM CARE;
MALE;
MONOTHERAPY;
MOUSE;
NONHUMAN;
STATISTICAL SIGNIFICANCE;
SUSPENSION;
|
EID: 0036267422
PISSN: 02537613
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (19)
|